Preparation and evaluation of PCL-PEG-PCL polymeric nanoparticles for doxorubicin delivery against breast cancer

RSC Advances

Volumn 6, Issue 60, 2016, Pages 54727-54737

  Zhang, Linhua ^a   Chen, Zhuo ^a   Wang, Hai ^a   Wu, Shengjie ^a   Zhao, Kongyin ^b   Sun, Hongfan ^a   Kong, Deling ^a   Wang, Chun ^a,c   Leng, Xigang ^a   Zhu, Dunwan ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^b TIANJIN POLYTECHNIC UNIVERSITY   (China)

^c University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCK COPOLYMERS; CELLS; CYTOLOGY; CYTOTOXICITY; DISEASES; ENCAPSULATION; FILM PREPARATION; FLUORESCENCE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

AMPHIPHILIC TRIBLOCK COPOLYMERS; CONFOCAL LASER SCANNING MICROSCOPY; CORE-SHELL MORPHOLOGIES; ENCAPSULATION EFFICIENCY; ENHANCED PERMEATION AND RETENTIONS; INTRACELLULAR DISTRIBUTION; NARROW SIZE DISTRIBUTIONS; POLYMERIC NANOPARTICLES;

POLYMERS;

EID: 84974694568     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c6ra04687h     Document Type: Article

References (52)

1. M. Alibolandi F. Sadeghi K. Abnous F. Atyabi M. Ramezani F. Hadizadeh The chemotherapeutic potential of doxorubicin-loaded PEG- b -PLGA nanopolymersomes in mouse breast cancer model Eur. J. Pharm. Biopharm. 2015 94 521 531
2. M. Li Z. Tang S. Lv et al. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin Biomaterials 2014 35 12 3851 3864
3. D. L. Hershman R. B. McBride A. Eisenberger W. Y. Tsai V. R. Grann J. S. Jacobson Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma J. Clin. Oncol. 2008 26 19 3159 3165
4. M. Gou H. Shi G. Guo et al. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles Nanotechnology 2011 22 9 095102
5. M. Wei X. Guo L. Tu et al. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma Int. J. Nanomed. 2015 10 5123 5137
6. Y. Nie L. Ji H. Ding et al. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization Theranostics 2012 2 11 1092 1103
7. C. Du D. Deng L. Shan et al. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery Biomaterials 2013 34 12 3087 3097
8. L. Zhou R. Cheng H. Tao et al. Endosomal pH-activatable poly(ethylene oxide)- graft -doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice Biomacromolecules 2011 12 5 1460 1467
9. R. Guha S. Chowdhury H. Palui et al. Doxorubicin-loaded MePEG-PCL nanoparticles for prevention of posterior capsular opacification Nanomedicine 2013 8 9 1415 1428
10. B. Tian Y. Ding J. Han J. Zhang Y. Han J. Han N -Acetyl-d-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: synthesis, characterization and in vitro evaluation Colloids Surf., B 2015 130 246 254
11. J. Zhang W. Tao Y. Chen et al. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy J. Mater. Sci. 2015 26 4 165
12. K. Wang X. Zhang Y. Liu C. Liu B. Jiang Y. Jiang Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates Biomaterials 2014 35 30 8735 8747
13. T. Etrych V. Subr R. Laga B. Rihova K. Ulbrich Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: impact of the carrier structure onto synergistic action in the treatment of solid tumours Eur. J. Pharm. Sci. 2014 58 1 12
14. A. Jain P. Kesharwani N. K. Garg et al. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin Colloids Surf., B 2015 134 47 58
15. L. Battaglia M. Gallarate E. Peira et al. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies J. Pharm. Sci. 2014 103 7 2157 2165
16. Y. T. Ko A. Kale W. C. Hartner B. Papahadjopoulos-Sternberg V. P. Torchilin Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery J. Controlled Release 2009 133 2 132 138
17. A. K. Jain A. Massey H. Yusuf D. M. McDonald H. O. McCarthy V. L. Kett Development of polymeric-cationic peptide composite nanoparticles, a nanoparticle-in-nanoparticle system for controlled gene delivery Int. J. Nanomed. 2015 10 7183 7196
18. M. Uchman P. Cigler B. Gruner K. Prochazka P. Matejicek Micelle-like nanoparticles of block copolymer poly(ethylene oxide)- block -poly(methacrylic acid) incorporating fluorescently substituted metallacarboranes designed as HIV protease inhibitor interaction probes J. Colloid Interface Sci. 2010 348 1 129 136
19. Y. Wang Y. X. Lin Z. Y. Qiao et al. Self-assembled autophagy-inducing polymeric nanoparticles for breast cancer interference in vivo Adv. Mater. 2015 27 16 2627 2634
20. F. Masood Polymeric nanoparticles for targeted drug delivery system for cancer therapy Mater. Sci. Eng., C 2016 60 569 578
21. L. Ruiyuan L. Yan Z. Zhenzhong Z. Xin Drug carriers based on highly protein-resistant materials for prolonged in vivo circulation time Regenerative Biomaterials 2015 2 2 125 133
22. Y. Dong S. S. Feng Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs Biomaterials 2004 25 14 2843 2849
23. Y. Li X. R. Qi Y. Maitani T. Nagai PEG-PLA diblock copolymer micelle-like nanoparticles as all- trans -retinoic acid carrier: in vitro and in vivo characterizations Nanotechnology 2009 20 5 055106
24. Y. Hu J. Xie Y. W. Tong C. H. Wang Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells J. Controlled Release 2007 118 1 7 17
25. A. Sosnik M. Menaker Raskin Polymeric micelles in mucosal drug delivery: challenges towards clinical translation Biotechnol. Adv. 2015 33 6 1380 1392
26. K. T. Oh Y. T. Oh N. M. Oh K. Kim D. H. Lee E. S. Lee A smart flower-like polymeric micelle for pH-triggered anticancer drug release Int. J. Pharm. 2009 375 1-2 163 169
27. M. A. Moretton R. J. Glisoni D. A. Chiappetta A. Sosnik Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles Colloids Surf., B 2010 79 2 467 479
28. H. Ge Y. Hu X. Jiang et al. Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles J. Pharm. Sci. 2002 91 6 1463 1473
29. X. Shan C. Liu Y. Yuan et al. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer Colloids Surf., B 2009 72 2 303 311
30. K. Remant Bahadur S. Bhattarai S. Aryal M. Khil N. Dharmaraj Novel amphiphilic triblock copolymer based on PPDO, PCL, and PEG: synthesis, characterization, and aqueous dispersion Colloids Surf., A 2007 292 1 69 78
31. M. Gou L. Zheng X. Peng et al. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro Int. J. Pharm. 2009 375 1-2 170 176
32. R. Feng Z. Song G. Zhai Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles Int. J. Nanomed. 2012 7 4089 4098
33. X. Gao B. Kan M. Gou et al. Preparation of anti-CD40 antibody modified magnetic PCL-PEG-PCL microspheres J. Biomed. Nanotechnol. 2011 7 2 285 291
34. L. Zhang Y. He G. Ma C. Song H. Sun Paclitaxel-loaded polymeric micelles based on poly(varepsilon-caprolactone)-poly(ethylene glycol)-poly(varepsilon-caprolactone) triblock copolymers: in vitro and in vivo evaluation Nanomedicine 2012 8 6 925 934
35. L. Zhang D. Zhu X. Dong et al. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery Int. J. Nanomed. 2015 10 2101 2114
36. A. J. Shuhendler P. Prasad R. X. Zhang et al. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model Mol. Pharmaceutics 2014 11 8 2659 2674
37. Z. Liu R. Cheung X. Y. Wu J. R. Ballinger R. Bendayan A. M. Rauth A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres J. Controlled Release 2001 77 3 213 224
38. Y. Zhong J. Zhang R. Cheng et al. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts J. Controlled Release 2015 205 144 154
39. L. Zhang J. Lu Y. Jin L. Qiu Folate-conjugated beta-cyclodextrin-based polymeric micelles with enhanced doxorubicin antitumor efficacy Colloids Surf., B 2014 122 260 269
40. L. Mei Y. Zhang Y. Zheng et al. A Novel Docetaxel-Loaded Poly(epsilon-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment Nanoscale Res. Lett. 2009 4 12 1530 1539
41. X. He L. Li H. Su et al. Poly(ethylene glycol)- block -poly(epsilon-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery Int. J. Nanomed. 2015 10 1791 1804
42. M. Mobed T. M. Chang Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications Biomaterials 1998 19 13 1167 1177
43. S. C. Woodward P. S. Brewer F. Moatamed A. Schindler C. G. Pitt The intracellular degradation of poly(epsilon-caprolactone) J. Biomed. Mater. Res. 1985 19 4 437 444
44. X. Shuai H. Ai N. Nasongkla S. Kim J. Gao Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery J. Controlled Release 2004 98 3 415 426
45. K. Kataoka T. Matsumoto M. Yokoyama et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance J. Controlled Release 2000 64 1-3 143 153
46. C. H. Wang C. H. Wang G. H. Hsiue Polymeric micelles with a pH-responsive structure as intracellular drug carriers J. Controlled Release 2005 108 1 140 149
47. R. Wei L. Cheng M. Zheng et al. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)- b -poly(N -2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release Biomacromolecules 2012 13 8 2429 2438
48. S. Lv Z. Tang M. Li et al. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer Biomaterials 2014 35 23 6118 6129
49. H. Xu D. Yang C. Cai et al. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation Acta Biomater. 2015 16 156 168
50. S. Tang Q. Yin Z. Zhang et al. Co-delivery of doxorubicin and RNA using pH-sensitive poly(beta-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer Biomaterials 2014 35 23 6047 6059
51. J. Fang H. Nakamura H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Delivery Rev. 2011 63 3 136 151
52. H. Maeda H. Nakamura J. Fang The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Adv. Drug Delivery Rev. 2013 65 1 71 79